[1]
U. Andersson, D. Johansson, P. Behnam-Motlagh, M. Johansson, and B. Malmer, “Treatment schedule is of importance when gefitinib is combined with irradiation of glioma and endothelial cells in vitro”, AO, vol. 46, no. 7, pp. 951–960, Jan. 2007.